IL17A and COVID-19: (62), observed significantly higher HLA-DR and CD38 expression, alongside elevated levels of numerous pro-inflammatory cytokines (IL-4, IL-7, IL-17, TNF-α) in CD4+ and CD8+ T cells in severe COVID-19 compared to mild and moderate patients, 3 months post infection.